Stockscreener 앱 받기
24.18
3.47%
-0.87
시간 외 거래:
24.18
Denali Therapeutics Inc 주식(DNLI)의 최신 뉴스
Denali Therapeutics (NASDAQ:DNLI) Trading Down 8.3%Here's What Happened - MarketBeat
Denali Has A Neurodegenerative Edge Despite Market Skepticism (NASDAQ:DNLI) - Seeking Alpha
Los Angeles Capital Management LLC Trims Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
We're Hopeful That Denali Therapeutics (NASDAQ:DNLI) Will Use Its Cash Wisely - Yahoo Finance
State of New Jersey Common Pension Fund D Sells 25,613 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Capital Research Global Investors Expands Stake in Denali Therap - GuruFocus.com
FMR LLC Expands Stake in Denali Therapeutics Inc - GuruFocus.com
BofA raises Denali Therapeutics target to $34 on BLA plans By Investing.com - Investing.com Canada
Denali Therapeutics executive sells shares worth $465,286 By Investing.com - Investing.com Australia
Denali Therapeutics executive sells shares worth $465,286 - Investing.com
Baillie Gifford & Co. Sells 417,709 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Principal Financial Group Inc. Increases Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Therapeutics stock soars to 52-week high of $32.17 - Investing.com India
Denali Therapeutics stock soars to 52-week high of $32.17 By Investing.com - Investing.com Canada
Learn to Evaluate (DNLI) using the Charts - Stock Traders Daily
Denali Therapeutics (NASDAQ:DNLI) Reaches New 12-Month HighStill a Buy? - MarketBeat
Wedbush Cuts Earnings Estimates for Denali Therapeutics - Defense World
Brokers Issue Forecasts for DNLI Q1 Earnings - MarketBeat
HC Wainwright Has Bearish Forecast for DNLI FY2024 Earnings - MarketBeat
Equities Analysts Offer Predictions for DNLI FY2024 Earnings - MarketBeat
Wellington Management Group LLP's Strategic Acquisition in Denal - GuruFocus.com
Denali Q3 Earnings Miss Estimates, Pipeline Progress Encouraging - Yahoo Finance
HC Wainwright Issues Pessimistic Forecast for DNLI Earnings - MarketBeat
Denali Therapeutics (NASDAQ:DNLI) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Denali Therapeutics (NASDAQ:DNLI) Given "Buy" Rating at HC Wainwright - MarketBeat
Denali Therapeutics earnings missed by $0.03, revenue topped estimates - Investing.com UK
Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire
Denali Therapeutics director Vicki Sato sells $83,375 in stock - Investing.com India
abrdn plc Sells 209,356 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Therapeutics (NASDAQ:DNLI) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - MarketBeat
Thinking about buying stock in QuickLogic, Ventyx Biosciences, D - GuruFocus.com
Denali Therapeutics Inc. (DNLI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Yahoo Finance
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives $38.22 Average Price Target from Analysts - MarketBeat
Zacks Research Issues Pessimistic Forecast for DNLI Earnings - MarketBeat
Denali Therapeutics CEO Ryan Watts sells shares worth $1.1 million - Investing.com
Insider Selling: Denali Therapeutics Inc. (NASDAQ:DNLI) CEO Sells 40,000 Shares of Stock - MarketBeat
(DNLI) Investment Analysis and Advice - Stock Traders Daily
The five-year returns have been notable for Denali Therapeutics (NASDAQ:DNLI) shareholders despite underlying losses increasing - Simply Wall St
Denali Therapeutics Inc (DNLI) stock on the rise: An overview - US Post News
Denali Therapeutics Inc (DNLI)’s Market Momentum: Closing Strong at 26.83, Down -4.18 - The Dwinnex
This trade activity should not be overlooked: Denali Therapeutics Inc (DNLI) - SETE News
Denali Therapeutics Inc (DNLI) receives a Mkt perform rating from Raymond James - Knox Daily
Denali Therapeutics (NASDAQ:DNLI) Price Target Lowered to $28.00 at JPMorgan Chase & Co. - Defense World
Hunter Syndrome Therapeutic Market Is in Huge Demand:Takeda, Denali Therapeutics, ArmaGen, Inventiva, Green Cross Corp, – IndiaPolitics.com - IndiaPolitics.com
Denali Therapeutics shares hold steady from BTIG By Investing.com - Investing.com South Africa
Denali Therapeutics (NASDAQ:DNLI) Shares Down 3.8% on Analyst Downgrade - MarketBeat
Denali Therapeutics Inc. (DNLI): Jeff Bezos Is Buying This Stock Now - Insider Monkey
Denali Therapeutics Inc. (NASDAQ:DNLI) Short Interest Update - MarketBeat
Denali Therapeutics (NASDAQ:DNLI) Trading 6.4% HigherTime to Buy? - MarketBeat
Sanofi, Denali face trial setback for neuro drug (NASDAQ:DNLI) - Seeking Alpha
JPMorgan Chase & Co. Cuts Denali Therapeutics (NASDAQ:DNLI) Price Target to $28.00 - MarketBeat
Denali Therapeutics Inc [DNLI] Director makes an insider purchase of 30,000 shares worth 0.87 million. - Knox Daily
3.66%
1.11%
자본화:
|
볼륨(24시간):